University Hospitals of Cleveland

Cleveland, Ohio 44195

9 studies enrolling now · 232 studies all time

What they study most

Acute Lung Injury, Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Acute Myocardial Infarction, Advanced Refractory Left Ventricular Heart Failure, Advanced Solid Tumors, Agammaglobulinemia, Alzheimer Disease, Amyotrophic Lateral Sclerosis (ALS), Anemia, Angioplasty, Transluminal, Percutaneous Coronary

Studies at this site

• Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study — Recruiting now
• Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells — Recruiting now
• A Study of ASP1002 in Adults for Treatment of Solid Tumors — Recruiting now
• Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature — Recruiting now
• Patient Retrospective Outcomes (PRO) — Recruiting now
• Deutetrabenazine Treatment for Tardive Dyskinesia in Intellectual/Developmental Disabilities — Recruiting now
• Bionic Pancreas in CFRD — Recruiting now
• NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness — Recruiting now
• Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma — Recruiting now
• CHAMPION-AF Clinical Trial — Running, not enrolling
• Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD) — Completed
• A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab — Running, not enrolling
• SIMPLAAFY Clinical Trial — Running, not enrolling
• "SALT Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia — Completed
• A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis — Running, not enrolling
• Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism — Running, not enrolling
• SDCC - Prospective Cohort Study of Chronic Renal Insufficiency — Running, not enrolling
• A 1-Year Study in Multiple Clinics Testing Rebamipide Eye Drops for Dry Eye Compared With a Placebo — Completed
• ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement — Running, not enrolling
• Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery — Running, not enrolling
• Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial — Running, not enrolling
• Brightline-1: A Study to Compare Brigimadlin (BI 907828) With Doxorubicin in People With a Type of Cancer Called Dedifferentiated Liposarcoma — Completed
• A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency — Completed
• BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis — Completed
• STIMULUS MDS-US : Sabatolimab Added to HMA in Higher Risk MDS — Stopped early
• Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer — Completed
• EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin) — Completed
• The LEADLESS II IDE Study for the Nanostim Leadless Pacemaker — Completed
• Venetoclax and Selinexor in Treating Patients with Relapsed or Refractory High Risk Hematologic Malignancies — Completed
• Valbenazine Treatment of Tardive Dyskinesia in Adults With Intellectual/Developmental Disabilities — Withdrawn before enrolling
• SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction — Completed
• My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors — Completed
• Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer — Stopped early
• The Adjunctive Use of Lavender and Peppermint Essential Oils — Completed
• Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM — Completed
• FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH) — Completed
• Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI) — Completed
• A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy — Completed
• TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer. — Completed
• ABSORB III Randomized Controlled Trial (RCT) — Completed
• Safety and Tolerability of Repeat Courses of IM Alefacept — Completed
• Efprezimod Alfa (CD24Fc, MK-7110) as a Non-antiviral Immunomodulator in COVID-19 Treatment (MK-7110-007) — Completed
• Safety and Efficacy Study of Sapanisertib in Combination With Exemestane or Fulvestrant in Postmenopausal Women With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Metastatic Breast Cancer — Completed
• Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse — Stopped early
• Use of Dexmedetomidine in Acute Stroke and Cerebral Vasospasm Interventions — Stopped early
• Evaluating the Safety and Effectiveness of Bone Marrow Transplants in Children With Sickle Cell Disease (BMT CTN 0601) — Completed
• TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy — Completed
• Symptomatic, Biomechanical and Radiographic Outcomes in Knee Osteoarthritis Following Gastric Bypass Surgery — Completed
• Efficacy of Celecoxib vs Placebo to Prevent Pain in a Paced Walk — Completed
• Effects of Inhibiting Early Inflammation in Kidney Transplant Patients — Completed